DeutschNewstral
Article
jdsupra.com on 2022-07-30 01:37
General Court Upholds European Commission’s Power to Review Illumina-Grail
Related news
- General Court Upholds European Commission’s Power to Review Illumina-Grail Despite Untriggered Turnover Thresholdsjdsupra.com
- EU General Court upholds European Commission’s decision on Illumina/GRAIL merger referraljdsupra.com
- Illumina/GRAIL: European Court of Justice Annuls the Commission’s Approachjdsupra.com
- New twist in the Illumina/GRAIL saga: Advocate General challenges European Commission’s power to review below-threshold mergersjdsupra.com
- General Court Decision in Illumina / Grail Vindicates Commission’s Article 22 Referral Policyjdsupra.com
- Illumina vs European Commission: the EU General Court endorses the Commission’s new approach to Article 22 EUMR allowing the capture of mergers below the thresholdsjdsupra.com
Illumina Battles U.S., European Antitrust Enforcers on Grail Dealwsj.com- Illumina/Grail: Court Opinion Could See an End to the EU Commission’s Expansive Merger Review Policyjdsupra.com
- EU General Court Backs the European Commission’s Right to Review Non-Reportable Dealsjdsupra.com
- General Court accepts the European Commission’s approach to catching concentrations that do not trigger any national thresholdsjdsupra.com
- European Commission’s record gun-jumping fine on Illumina serves as warning to merging partiesjdsupra.com
- Illumina/Grail: EU Court Overturns Below-Threshold Merger Review Policyjdsupra.com
- Illumina/GRAIL: EU General Court gives green light to below-threshold merger referralsjdsupra.com
- The European Commission’s Proposed Directive 2022/0051jdsupra.com
- One Stop Shop Called Into Question – EU General Court Confirms the European Commission’s Stance On Referrals of Non-Notifiable Deals From National Competition Authoritiesjdsupra.com
Illumina Inc: Grail alumni say Illumina battle threatens cancer breakthroughFinancial Times- MFTC orders Illumina to divest Grail acquisitionmvtelegraph.com
Illumina to divest cancer test maker GrailNew York Post- The European Commission’s New Pharmaceutical Strategy For Europejdsupra.com
- EU General Court backs European Commission’s tough stance on merger control “gun jumping”jdsupra.com